abstract |
The present invention provides compounds that are inducers or inhibitors of apoptosis after apoptosis or cell cycle arrest. The present invention further provides pharmaceutical compositions and methods for the treatment of mammals suffering from leukemia or other forms of cancer and for the treatment of disease states caused by cellular apoptosis. [Chemical 1] |